Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and Vemurafenib

Publisher： Karger

E-ISSN： 2296-5262|40|4|174-183

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.40, Iss.4, 2017-03, pp. : 174-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab

By  

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 1, 2018-01 ,pp. : e21-e22

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-05 ,pp. : 285-288

Karger

Access to resources Recommend Favorite

Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumab

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 32, Iss. 1, 2018-01 ,pp. : e26-e28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Late-Onset Paraplegia after Complete Response to Two Cycles of Ipilimumab for Metastatic Melanoma

By  

Oncology Research and Treatment, Vol. 37, Iss. 12, 2014-10 ,pp. : 757-760

Karger

Access to resources Recommend Favorite

Clinical activity of ipilimumab for metastatic uveal melanoma

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3687-3695

John Wiley & Sons Inc

Access to resources Recommend Favorite